Future Growth of OTC Market

Bring your input to OTC Drugs: U.S. Competitor Cost Structures 2010

Kline is  pleased to announce that our research has begun for the OTC Drugs: U.S. Competitor Cost Structures 2010 study.
Our lead research analyst, Mr. Prashant Sharma, is currently in touch with suppliers, manufacturers, packaging companies, ad agencies, financial analysts, and OTC marketers to understand how their cost structures have changed recently.

We would like your valuable input as well on the following:

  • How are industry cost structures affected by the way operations are organized and run?
  • How do companies in the industry control and reduce costs by outsourcing, intelligent resource allocation, and carefully managed product portfolios?
  • How have costs evolved between 2005, 2008, and the first half of 2009, and how are OTC companies shifting costs for coping with the recession?
  • Where do specific companies stand in terms of cost performance when compared to direct competitors?
To participate in the research, please contact Prashant at Prashant.Sharma@klinegroup.com or 973-435-3414. All information gathered from these interviews is kept strictly confidential and is aggregated to form Kline’s estimates.
If you are interested in purchasing this study, please note we are offering a 15% discount off the standard price through July 31, 2010.

Bookmark Bring your input to OTC Drugs: U.S. Competitor Cost Structures 2010

Share this
Posted in Healthcare.

Leave a Reply